Incyte INCY
NASDAQ INCY
$117.14 -4.21 (-3.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Incyte (INCY) Current Deferred Tax Assets (2013 - 2015)

Updated

Incyte (INCY) posted Current Deferred Tax Assets of $9.71 million for Q3 2015, compared with $775,000 a year earlier and up 25.7% from the prior quarter.

Analysis

Incyte (INCY) Current Deferred Tax Assets (2013 - 2015) Analysis & Trends

At the end of FY2014, Incyte's Current Deferred Tax Assets came in at $19.64 million.

  • In prior years, Incyte's Current Deferred Tax Assets was $895,000 in FY2013.
  • Quarterly Current Deferred Tax Assets has run from a low of $775,000 in Q3 2014 to a high of $19.64 million in Q4 2014 over five years.
  • According to Business Quant data, Current Deferred Tax Assets for the three prior quarters was $7.73 million (Q2 2015), $6.03 million (Q1 2015) and $19.64 million (Q4 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Incyte 24.39 Bn 9.33 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 9.71 Mn
Jun 30, 2015 7.73 Mn
Mar 31, 2015 6.03 Mn
Dec 31, 2014 19.64 Mn
Sep 30, 2014 775,000.00
Jun 30, 2014 900,000.00
Mar 31, 2014 892,000.00
Dec 31, 2013 895,000.00
API Access

Incyte Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=INCY&period=max&api_key=YOUR_API_KEY